Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

HRT patches prevent the side-effect of osteoporosis when used as a treatment for advanced prostate cancer

15.11.2004


Men using the female estrogen hormone replacement therapy (HRT) patches as treatment for advanced prostate cancer suffer fewer side effects than with other treatments, according to a new study reported in the latest issue of the Journal of Urology (December 2004). Scientists at Hammersmith Hospitals NHS Trust and Imperial College London have already shown that HRT patches have considerable potential as prostate cancer therapy. For the first time they have additionally shown that this therapy, unlike other current treatments, prevents bone loss (osteoporosis) and instead causes an increase in bone density. These early studies confirm the considerable promise of estrogen hormone patches in advanced prostate cancer.



Prostate cancer is the most common male cancer in the UK, with about 20,000 cases diagnosed every year. Affecting men generally over the age of 45, prostate cancer grows slowly and may go undetected for many years. In some cases, the cancer can spread to bones and other organs of the body. The causes of prostate cancer are mainly unknown, but it requires the male hormone testosterone, produced in the testicles, to develop and grow. Treatment of advanced disease has resulted in therapies that reduce or remove testosterone from the body, via surgical or medical ‘castration.’

“Depriving the cancer of testosterone is the well accepted method of slowing down the progression of advanced prostate cancer,” comments lead author Mr Paul Abel, consultant urologist at Hammersmith Hospitals NHS Trust and Imperial College London. “The problem is that conventional current therapies which involve testosterone reduction can have serious side effects such as osteoporosis, which has not been fully appreciated until quite recently. This has led to reports of an increasing chance of bone fractures in these patients. Our study shows that oestrogen therapy delivered by skin patches not only controls prostate cancer, but prevents bone loss and in most cases, increases bone mass.”


Osteoporosis is a disease in which bones, particularly in the hip, spine and wrist, become fragile and more likely to break. The risk of hip fracture is serious, as it almost always requires hospitalisation and major surgery. It can impair a person’s ability to walk unassisted and may cause permanent disability. Spinal or vertebral fractures also have serious consequences, including severe back pain and deformity. Once viewed primarily as a women’s disease, osteoporosis is becoming increasingly important as prostate cancer sufferers survive for longer periods of time.

The study looked at 20 men with late stage prostate cancer who were given oestrogen hormone replacement therapy skin patches, and measured bone mass using an advanced imaging technique known as x-ray bone densiometry. Average increase in bone density was over 3%, with almost all patients gaining bone density to some extent. “Patients having conventional prostate cancer treatment can lose between 2 and 10% of their bone mass alone in the first year of treatment with an increasing risk of bone fracture the longer treatment continues,” explains Mr Abel, “whereas the increase in bone mass we have seen in this trial is by contrast promising news.”

Larger trials of the HRT patch therapy for prostate cancer are planned so that long-term effectiveness and side effects of this therapy can be clarified. They will take place before this treatment is offered routinely on the NHS.

The researchers are very encouraged by the results so far, which also hold considerable promise for healthcare cost reductions. Hormone patches cost about one tenth of conventional single treatments. “There is potential for a cost saving of over US$2 billion in advanced prostate cancer treatment if this therapy is rolled out worldwide," adds Mr Abel.

Simon Wilde | alfa
Further information:
http://www.hhnt.nhs.uk

More articles from Health and Medicine:

nachricht New antibody analysis accelerates rational vaccine design
09.08.2018 | Scripps Research Institute

nachricht Distrust of power influences choice of medical procedures
01.08.2018 | Johannes Gutenberg-Universität Mainz

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

Im Focus: Lining up surprising behaviors of superconductor with one of the world's strongest magnets

Scientists have discovered that the electrical resistance of a copper-oxide compound depends on the magnetic field in a very unusual way -- a finding that could help direct the search for materials that can perfectly conduct electricity at room temperatur

What happens when really powerful magnets--capable of producing magnetic fields nearly two million times stronger than Earth's--are applied to materials that...

Im Focus: World record: Fastest 3-D tomographic images at BESSY II

The quality of materials often depends on the manufacturing process. In casting and welding, for example, the rate at which melts solidify and the resulting microstructure of the alloy is important. With metallic foams as well, it depends on exactly how the foaming process takes place. To understand these processes fully requires fast sensing capability. The fastest 3D tomographic images to date have now been achieved at the BESSY II X-ray source operated by the Helmholtz-Zentrum Berlin.

Dr. Francisco Garcia-Moreno and his team have designed a turntable that rotates ultra-stably about its axis at a constant rotational speed. This really depends...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

2018 Work Research Conference

25.07.2018 | Event News

 
Latest News

'Building up' stretchable electronics to be as multipurpose as your smartphone

14.08.2018 | Information Technology

During HIV infection, antibody can block B cells from fighting pathogens

14.08.2018 | Life Sciences

First study on physical properties of giant cancer cells may inform new treatments

14.08.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>